α-Cobratoxin May Be Treatment for Lung Cancer
June 17th, 2009
In a mouse model of advanced non-small cell lung cancer, treatment with the nicotinic acetylcholine receptor antagonist α-cobratoxin (α-CbT) was associated with improved survival, according to research published in the June 15 issue of the American Journal of Respiratory and Critical Care Medicine.